img

Global Isoxsuprine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Isoxsuprine Market Research Report 2024

Isoxsuprine (used as isoxsuprine hydrochloride) is a drug used as a vasodilator in humans (under the trade name Duvadilan) and equines. Isoxsuprine is a β2 adrenoreceptor agonist that causes direct relaxation of uterine and vascular smooth muscle via β2 receptors.
According to Mr Accuracy reports’s new survey, global Isoxsuprine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Isoxsuprine market research.
Key manufacturers engaged in the Isoxsuprine industry include Pharco, Invision Pharma, Zenon Healthcare, Systemic, Wockhardt, Solvay Pharma, Glenmark, Bristol-Myers Squibb and Merck Sharp and Dohme, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Isoxsuprine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Isoxsuprine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Isoxsuprine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pharco
Invision Pharma
Zenon Healthcare
Systemic
Wockhardt
Solvay Pharma
Glenmark
Bristol-Myers Squibb
Merck Sharp and Dohme
Amriya
Pfizer
Winston Pharma
Johnson and Johnson
Aspen Pharmacare
Abbott
Drugmaker's Laboratoires
Segment by Type
Use in Humans
Use in Animals

Segment by Application


Peripheral Vasodilator
β-Sympathomimetic Agent

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Isoxsuprine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Isoxsuprine Market Overview
1.1 Product Overview and Scope of Isoxsuprine
1.2 Isoxsuprine Segment by Type
1.2.1 Global Isoxsuprine Market Value Comparison by Type (2024-2034)
1.2.2 Use in Humans
1.2.3 Use in Animals
1.3 Isoxsuprine Segment by Application
1.3.1 Global Isoxsuprine Market Value by Application: (2024-2034)
1.3.2 Peripheral Vasodilator
1.3.3 β-Sympathomimetic Agent
1.4 Global Isoxsuprine Market Size Estimates and Forecasts
1.4.1 Global Isoxsuprine Revenue 2018-2034
1.4.2 Global Isoxsuprine Sales 2018-2034
1.4.3 Global Isoxsuprine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Isoxsuprine Market Competition by Manufacturers
2.1 Global Isoxsuprine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Isoxsuprine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Isoxsuprine Average Price by Manufacturers (2018-2024)
2.4 Global Isoxsuprine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Isoxsuprine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Isoxsuprine, Product Type & Application
2.7 Isoxsuprine Market Competitive Situation and Trends
2.7.1 Isoxsuprine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Isoxsuprine Players Market Share by Revenue
2.7.3 Global Isoxsuprine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Isoxsuprine Retrospective Market Scenario by Region
3.1 Global Isoxsuprine Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Isoxsuprine Global Isoxsuprine Sales by Region: 2018-2034
3.2.1 Global Isoxsuprine Sales by Region: 2018-2024
3.2.2 Global Isoxsuprine Sales by Region: 2024-2034
3.3 Global Isoxsuprine Global Isoxsuprine Revenue by Region: 2018-2034
3.3.1 Global Isoxsuprine Revenue by Region: 2018-2024
3.3.2 Global Isoxsuprine Revenue by Region: 2024-2034
3.4 North America Isoxsuprine Market Facts & Figures by Country
3.4.1 North America Isoxsuprine Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Isoxsuprine Sales by Country (2018-2034)
3.4.3 North America Isoxsuprine Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Isoxsuprine Market Facts & Figures by Country
3.5.1 Europe Isoxsuprine Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Isoxsuprine Sales by Country (2018-2034)
3.5.3 Europe Isoxsuprine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Isoxsuprine Market Facts & Figures by Country
3.6.1 Asia Pacific Isoxsuprine Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Isoxsuprine Sales by Country (2018-2034)
3.6.3 Asia Pacific Isoxsuprine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Isoxsuprine Market Facts & Figures by Country
3.7.1 Latin America Isoxsuprine Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Isoxsuprine Sales by Country (2018-2034)
3.7.3 Latin America Isoxsuprine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Isoxsuprine Market Facts & Figures by Country
3.8.1 Middle East and Africa Isoxsuprine Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Isoxsuprine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Isoxsuprine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Isoxsuprine Sales by Type (2018-2034)
4.1.1 Global Isoxsuprine Sales by Type (2018-2024)
4.1.2 Global Isoxsuprine Sales by Type (2024-2034)
4.1.3 Global Isoxsuprine Sales Market Share by Type (2018-2034)
4.2 Global Isoxsuprine Revenue by Type (2018-2034)
4.2.1 Global Isoxsuprine Revenue by Type (2018-2024)
4.2.2 Global Isoxsuprine Revenue by Type (2024-2034)
4.2.3 Global Isoxsuprine Revenue Market Share by Type (2018-2034)
4.3 Global Isoxsuprine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Isoxsuprine Sales by Application (2018-2034)
5.1.1 Global Isoxsuprine Sales by Application (2018-2024)
5.1.2 Global Isoxsuprine Sales by Application (2024-2034)
5.1.3 Global Isoxsuprine Sales Market Share by Application (2018-2034)
5.2 Global Isoxsuprine Revenue by Application (2018-2034)
5.2.1 Global Isoxsuprine Revenue by Application (2018-2024)
5.2.2 Global Isoxsuprine Revenue by Application (2024-2034)
5.2.3 Global Isoxsuprine Revenue Market Share by Application (2018-2034)
5.3 Global Isoxsuprine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Pharco
6.1.1 Pharco Corporation Information
6.1.2 Pharco Description and Business Overview
6.1.3 Pharco Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Pharco Isoxsuprine Product Portfolio
6.1.5 Pharco Recent Developments/Updates
6.2 Invision Pharma
6.2.1 Invision Pharma Corporation Information
6.2.2 Invision Pharma Description and Business Overview
6.2.3 Invision Pharma Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Invision Pharma Isoxsuprine Product Portfolio
6.2.5 Invision Pharma Recent Developments/Updates
6.3 Zenon Healthcare
6.3.1 Zenon Healthcare Corporation Information
6.3.2 Zenon Healthcare Description and Business Overview
6.3.3 Zenon Healthcare Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Zenon Healthcare Isoxsuprine Product Portfolio
6.3.5 Zenon Healthcare Recent Developments/Updates
6.4 Systemic
6.4.1 Systemic Corporation Information
6.4.2 Systemic Description and Business Overview
6.4.3 Systemic Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Systemic Isoxsuprine Product Portfolio
6.4.5 Systemic Recent Developments/Updates
6.5 Wockhardt
6.5.1 Wockhardt Corporation Information
6.5.2 Wockhardt Description and Business Overview
6.5.3 Wockhardt Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Wockhardt Isoxsuprine Product Portfolio
6.5.5 Wockhardt Recent Developments/Updates
6.6 Solvay Pharma
6.6.1 Solvay Pharma Corporation Information
6.6.2 Solvay Pharma Description and Business Overview
6.6.3 Solvay Pharma Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Solvay Pharma Isoxsuprine Product Portfolio
6.6.5 Solvay Pharma Recent Developments/Updates
6.7 Glenmark
6.6.1 Glenmark Corporation Information
6.6.2 Glenmark Description and Business Overview
6.6.3 Glenmark Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Glenmark Isoxsuprine Product Portfolio
6.7.5 Glenmark Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Corporation Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Bristol-Myers Squibb Isoxsuprine Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Merck Sharp and Dohme
6.9.1 Merck Sharp and Dohme Corporation Information
6.9.2 Merck Sharp and Dohme Description and Business Overview
6.9.3 Merck Sharp and Dohme Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Merck Sharp and Dohme Isoxsuprine Product Portfolio
6.9.5 Merck Sharp and Dohme Recent Developments/Updates
6.10 Amriya
6.10.1 Amriya Corporation Information
6.10.2 Amriya Description and Business Overview
6.10.3 Amriya Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Amriya Isoxsuprine Product Portfolio
6.10.5 Amriya Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Isoxsuprine Description and Business Overview
6.11.3 Pfizer Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Pfizer Isoxsuprine Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Winston Pharma
6.12.1 Winston Pharma Corporation Information
6.12.2 Winston Pharma Isoxsuprine Description and Business Overview
6.12.3 Winston Pharma Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Winston Pharma Isoxsuprine Product Portfolio
6.12.5 Winston Pharma Recent Developments/Updates
6.13 Johnson and Johnson
6.13.1 Johnson and Johnson Corporation Information
6.13.2 Johnson and Johnson Isoxsuprine Description and Business Overview
6.13.3 Johnson and Johnson Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Johnson and Johnson Isoxsuprine Product Portfolio
6.13.5 Johnson and Johnson Recent Developments/Updates
6.14 Aspen Pharmacare
6.14.1 Aspen Pharmacare Corporation Information
6.14.2 Aspen Pharmacare Isoxsuprine Description and Business Overview
6.14.3 Aspen Pharmacare Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Aspen Pharmacare Isoxsuprine Product Portfolio
6.14.5 Aspen Pharmacare Recent Developments/Updates
6.15 Abbott
6.15.1 Abbott Corporation Information
6.15.2 Abbott Isoxsuprine Description and Business Overview
6.15.3 Abbott Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Abbott Isoxsuprine Product Portfolio
6.15.5 Abbott Recent Developments/Updates
6.16 Drugmaker's Laboratoires
6.16.1 Drugmaker's Laboratoires Corporation Information
6.16.2 Drugmaker's Laboratoires Isoxsuprine Description and Business Overview
6.16.3 Drugmaker's Laboratoires Isoxsuprine Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Drugmaker's Laboratoires Isoxsuprine Product Portfolio
6.16.5 Drugmaker's Laboratoires Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Isoxsuprine Industry Chain Analysis
7.2 Isoxsuprine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Isoxsuprine Production Mode & Process
7.4 Isoxsuprine Sales and Marketing
7.4.1 Isoxsuprine Sales Channels
7.4.2 Isoxsuprine Distributors
7.5 Isoxsuprine Customers
8 Isoxsuprine Market Dynamics
8.1 Isoxsuprine Industry Trends
8.2 Isoxsuprine Market Drivers
8.3 Isoxsuprine Market Challenges
8.4 Isoxsuprine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Isoxsuprine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Isoxsuprine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Isoxsuprine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Isoxsuprine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Isoxsuprine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Isoxsuprine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Isoxsuprine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Isoxsuprine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Isoxsuprine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Isoxsuprine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Isoxsuprine, Product Type & Application
Table 12. Global Key Manufacturers of Isoxsuprine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Isoxsuprine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isoxsuprine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Isoxsuprine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Isoxsuprine Sales by Region (2018-2024) & (K Units)
Table 18. Global Isoxsuprine Sales Market Share by Region (2018-2024)
Table 19. Global Isoxsuprine Sales by Region (2024-2034) & (K Units)
Table 20. Global Isoxsuprine Sales Market Share by Region (2024-2034)
Table 21. Global Isoxsuprine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Isoxsuprine Revenue Market Share by Region (2018-2024)
Table 23. Global Isoxsuprine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Isoxsuprine Revenue Market Share by Region (2024-2034)
Table 25. North America Isoxsuprine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Isoxsuprine Sales by Country (2018-2024) & (K Units)
Table 27. North America Isoxsuprine Sales by Country (2024-2034) & (K Units)
Table 28. North America Isoxsuprine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Isoxsuprine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Isoxsuprine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Isoxsuprine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Isoxsuprine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Isoxsuprine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Isoxsuprine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Isoxsuprine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Isoxsuprine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Isoxsuprine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Isoxsuprine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Isoxsuprine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Isoxsuprine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Isoxsuprine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Isoxsuprine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Isoxsuprine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Isoxsuprine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Isoxsuprine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Isoxsuprine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Isoxsuprine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Isoxsuprine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Isoxsuprine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Isoxsuprine Sales (K Units) by Type (2018-2024)
Table 51. Global Isoxsuprine Sales (K Units) by Type (2024-2034)
Table 52. Global Isoxsuprine Sales Market Share by Type (2018-2024)
Table 53. Global Isoxsuprine Sales Market Share by Type (2024-2034)
Table 54. Global Isoxsuprine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Isoxsuprine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Isoxsuprine Revenue Market Share by Type (2018-2024)
Table 57. Global Isoxsuprine Revenue Market Share by Type (2024-2034)
Table 58. Global Isoxsuprine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Isoxsuprine Price (US$/Unit) by Type (2024-2034)
Table 60. Global Isoxsuprine Sales (K Units) by Application (2018-2024)
Table 61. Global Isoxsuprine Sales (K Units) by Application (2024-2034)
Table 62. Global Isoxsuprine Sales Market Share by Application (2018-2024)
Table 63. Global Isoxsuprine Sales Market Share by Application (2024-2034)
Table 64. Global Isoxsuprine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Isoxsuprine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Isoxsuprine Revenue Market Share by Application (2018-2024)
Table 67. Global Isoxsuprine Revenue Market Share by Application (2024-2034)
Table 68. Global Isoxsuprine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Isoxsuprine Price (US$/Unit) by Application (2024-2034)
Table 70. Pharco Corporation Information
Table 71. Pharco Description and Business Overview
Table 72. Pharco Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Pharco Isoxsuprine Product
Table 74. Pharco Recent Developments/Updates
Table 75. Invision Pharma Corporation Information
Table 76. Invision Pharma Description and Business Overview
Table 77. Invision Pharma Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Invision Pharma Isoxsuprine Product
Table 79. Invision Pharma Recent Developments/Updates
Table 80. Zenon Healthcare Corporation Information
Table 81. Zenon Healthcare Description and Business Overview
Table 82. Zenon Healthcare Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Zenon Healthcare Isoxsuprine Product
Table 84. Zenon Healthcare Recent Developments/Updates
Table 85. Systemic Corporation Information
Table 86. Systemic Description and Business Overview
Table 87. Systemic Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Systemic Isoxsuprine Product
Table 89. Systemic Recent Developments/Updates
Table 90. Wockhardt Corporation Information
Table 91. Wockhardt Description and Business Overview
Table 92. Wockhardt Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Wockhardt Isoxsuprine Product
Table 94. Wockhardt Recent Developments/Updates
Table 95. Solvay Pharma Corporation Information
Table 96. Solvay Pharma Description and Business Overview
Table 97. Solvay Pharma Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Solvay Pharma Isoxsuprine Product
Table 99. Solvay Pharma Recent Developments/Updates
Table 100. Glenmark Corporation Information
Table 101. Glenmark Description and Business Overview
Table 102. Glenmark Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Glenmark Isoxsuprine Product
Table 104. Glenmark Recent Developments/Updates
Table 105. Bristol-Myers Squibb Corporation Information
Table 106. Bristol-Myers Squibb Description and Business Overview
Table 107. Bristol-Myers Squibb Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Bristol-Myers Squibb Isoxsuprine Product
Table 109. Bristol-Myers Squibb Recent Developments/Updates
Table 110. Merck Sharp and Dohme Corporation Information
Table 111. Merck Sharp and Dohme Description and Business Overview
Table 112. Merck Sharp and Dohme Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Merck Sharp and Dohme Isoxsuprine Product
Table 114. Merck Sharp and Dohme Recent Developments/Updates
Table 115. Amriya Corporation Information
Table 116. Amriya Description and Business Overview
Table 117. Amriya Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Amriya Isoxsuprine Product
Table 119. Amriya Recent Developments/Updates
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Pfizer Isoxsuprine Product
Table 124. Pfizer Recent Developments/Updates
Table 125. Winston Pharma Corporation Information
Table 126. Winston Pharma Description and Business Overview
Table 127. Winston Pharma Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Winston Pharma Isoxsuprine Product
Table 129. Winston Pharma Recent Developments/Updates
Table 130. Johnson and Johnson Corporation Information
Table 131. Johnson and Johnson Description and Business Overview
Table 132. Johnson and Johnson Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Johnson and Johnson Isoxsuprine Product
Table 134. Johnson and Johnson Recent Developments/Updates
Table 135. Aspen Pharmacare Corporation Information
Table 136. Aspen Pharmacare Description and Business Overview
Table 137. Aspen Pharmacare Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Aspen Pharmacare Isoxsuprine Product
Table 139. Aspen Pharmacare Recent Developments/Updates
Table 140. Abbott Corporation Information
Table 141. Abbott Description and Business Overview
Table 142. Abbott Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Abbott Isoxsuprine Product
Table 144. Abbott Recent Developments/Updates
Table 145. Drugmaker's Laboratoires Corporation Information
Table 146. Drugmaker's Laboratoires Description and Business Overview
Table 147. Drugmaker's Laboratoires Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Drugmaker's Laboratoires Isoxsuprine Product
Table 149. Drugmaker's Laboratoires Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Isoxsuprine Distributors List
Table 153. Isoxsuprine Customers List
Table 154. Isoxsuprine Market Trends
Table 155. Isoxsuprine Market Drivers
Table 156. Isoxsuprine Market Challenges
Table 157. Isoxsuprine Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Isoxsuprine
Figure 2. Global Isoxsuprine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Isoxsuprine Market Share by Type in 2022 & 2034
Figure 4. Use in Humans Product Picture
Figure 5. Use in Animals Product Picture
Figure 6. Global Isoxsuprine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Isoxsuprine Market Share by Application in 2022 & 2034
Figure 8. Peripheral Vasodilator
Figure 9. β-Sympathomimetic Agent
Figure 10. Global Isoxsuprine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 11. Global Isoxsuprine Market Size (2018-2034) & (US$ Million)
Figure 12. Global Isoxsuprine Sales (2018-2034) & (K Units)
Figure 13. Global Isoxsuprine Average Price (US$/Unit) & (2018-2034)
Figure 14. Isoxsuprine Report Years Considered
Figure 15. Isoxsuprine Sales Share by Manufacturers in 2022
Figure 16. Global Isoxsuprine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Isoxsuprine Players: Market Share by Revenue in 2022
Figure 18. Isoxsuprine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Isoxsuprine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 20. North America Isoxsuprine Sales Market Share by Country (2018-2034)
Figure 21. North America Isoxsuprine Revenue Market Share by Country (2018-2034)
Figure 22. United States Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe Isoxsuprine Sales Market Share by Country (2018-2034)
Figure 25. Europe Isoxsuprine Revenue Market Share by Country (2018-2034)
Figure 26. Germany Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific Isoxsuprine Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific Isoxsuprine Revenue Market Share by Region (2018-2034)
Figure 33. China Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. China Taiwan Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Indonesia Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Thailand Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Malaysia Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Latin America Isoxsuprine Sales Market Share by Country (2018-2034)
Figure 43. Latin America Isoxsuprine Revenue Market Share by Country (2018-2034)
Figure 44. Mexico Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Brazil Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Argentina Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Isoxsuprine Sales Market Share by Country (2018-2034)
Figure 48. Middle East & Africa Isoxsuprine Revenue Market Share by Country (2018-2034)
Figure 49. Turkey Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Saudi Arabia Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. UAE Isoxsuprine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Isoxsuprine by Type (2018-2034)
Figure 53. Global Revenue Market Share of Isoxsuprine by Type (2018-2034)
Figure 54. Global Isoxsuprine Price (US$/Unit) by Type (2018-2034)
Figure 55. Global Sales Market Share of Isoxsuprine by Application (2018-2034)
Figure 56. Global Revenue Market Share of Isoxsuprine by Application (2018-2034)
Figure 57. Global Isoxsuprine Price (US$/Unit) by Application (2018-2034)
Figure 58. Isoxsuprine Value Chain
Figure 59. Isoxsuprine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed